Business · 12/08/2015

FDA Extends Closing Date for Generic Drug User Fee Amendments of 2012 Reauthorization Stakeholder Meetings

The Food and Drug Administration (FDA) is extending the deadline for public stakeholders to notify their intent to participate in periodic consultation meetings on the reauthorization of the Generic Drug User Fee Amendments of 2012 (GDUFA), which is set to expire at the end of September 2017.